TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Return 18.15%
This Quarter Return
+1.3%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.45B
AUM Growth
-$11.8M
Cap. Flow
-$7.06M
Cap. Flow %
-0.29%
Top 10 Hldgs %
40.31%
Holding
207
New
13
Increased
45
Reduced
58
Closed
10

Sector Composition

1 Healthcare 95.11%
2 Real Estate 2.46%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WHWK
176
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
$673K 0.03%
49,333
RGNX icon
177
Regenxbio
RGNX
$490M
$658K 0.03%
+12,801
New +$658K
CBAY
178
DELISTED
Cymabay Therapeutics
CBAY
$631K 0.03%
+88,102
New +$631K
RARX
179
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$577K 0.02%
+19,190
New +$577K
MYGN icon
180
Myriad Genetics
MYGN
$615M
$571K 0.02%
20,549
CLVS
181
DELISTED
Clovis Oncology, Inc.
CLVS
$561K 0.02%
37,700
-37,700
-50% -$561K
RYTM icon
182
Rhythm Pharmaceuticals
RYTM
$6.78B
$548K 0.02%
24,890
CYH icon
183
Community Health Systems
CYH
$409M
$545K 0.02%
203,935
FATE icon
184
Fate Therapeutics
FATE
$116M
$495K 0.02%
+24,379
New +$495K
CMRX
185
DELISTED
Chimerix, Inc.
CMRX
$494K 0.02%
+114,333
New +$494K
TTPH
186
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$413K 0.02%
42,966
IMGN
187
DELISTED
Immunogen Inc
IMGN
$365K 0.01%
168,190
MNK
188
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$303K 0.01%
32,980
CAH icon
189
Cardinal Health
CAH
$35.7B
$297K 0.01%
6,300
CDTX icon
190
Cidara Therapeutics
CDTX
$1.6B
$267K 0.01%
7,939
ORKA
191
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
$264K 0.01%
3,006
-750
-20% -$65.9K
NVAX icon
192
Novavax
NVAX
$1.28B
$167K 0.01%
28,550
CLSD icon
193
Clearside Biomedical
CLSD
$27.2M
$161K 0.01%
165,330
TRIL
194
DELISTED
Trillium Therapeutics Inc.
TRIL
$146K 0.01%
446,099
BLCM
195
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$102K ﹤0.01%
6,000
QHC
196
DELISTED
Quorum Health Corporation
QHC
$33K ﹤0.01%
23,725
CLDX icon
197
Celldex Therapeutics
CLDX
$1.52B
$19K ﹤0.01%
7,053
AKBA icon
198
Akebia Therapeutics
AKBA
$785M
-213,942
Closed -$1.75M
CNC icon
199
Centene
CNC
$14.2B
-128,295
Closed -$6.81M
DNLI icon
200
Denali Therapeutics
DNLI
$2.26B
-19,372
Closed -$450K